Clinical Trial Update: Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This document reports dose-finding results for lenalidomide used as maintenance therapy in patients with multiple myeloma in a Phase 1/2 trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED